{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:05:33Z","timestamp":1786993533409,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T00:00:00Z","timestamp":1497484800000},"content-version":"vor","delay-in-days":745,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jvascsurg.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jvs.2014.12.062","type":"journal-article","created":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T00:03:31Z","timestamp":1424304211000},"page":"1479-1488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Safety and efficacy of antiplatelet\/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease"],"prefix":"10.1016","volume":"61","author":[{"given":"Brant W.","family":"Ullery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Itoga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald L.","family":"Dalman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason T.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2014.12.062_bib1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1051-0443(99)70064-3","article-title":"Histopathologic evaluation of an expanded polytetrafluoroethylene-nitinol stent endoprosthesis in canine iliofemoral arteries","volume":"10","author":"Virmani","year":"1999","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2014.12.062_bib2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/0741-5214(90)90082-L","article-title":"Healing of polytetrafluoroethylene arterial grafts is influenced by graft porosity","volume":"11","author":"Golden","year":"1990","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2014.12.062_bib3","first-page":"443","article-title":"Improved patency and reduced intimal hyperplasia in PTFE grafts with luminal immobilized heparin compared with standard PTFE grafts at six months in a sheep model","volume":"51","author":"Pedersen","year":"2010","journal-title":"J\u00a0Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.jvs.2014.12.062_bib4","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jacc.2013.05.079","volume":"62","author":"Lammer","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2014.12.062_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2014.12.062_bib6","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2014.12.062_bib7","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2014.12.062_bib8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jvs.2014.04.061","article-title":"Disease-specific guidelines for reporting adverse events for peripheral vascular medical devices","volume":"60","author":"Ouriel","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2014.12.062_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jvs.2012.01.004","article-title":"Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients","volume":"56","author":"Monaco","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2014.12.062_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa065959","article-title":"Oral anticoagulant and antiplatelet therapy and peripheral artery disease","volume":"357","author":"Anand","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2014.12.062_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.avsg.2012.05.001","article-title":"Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures","volume":"27","author":"Allemang","year":"2013","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2014.12.062_bib12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jvs.2013.01.050","article-title":"Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease","volume":"58","author":"Geraghty","year":"2013","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2014.12.062_bib13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jvs.2010.03.071","article-title":"Four-year randomized prospective comparison of percutaneous ePTFE\/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease","volume":"52","author":"McQuade","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2014.12.062_bib14","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/1538574413495964","article-title":"Is there an alternative to the surgical above-knee bypass in treatment of superficial femoral artery disease? Experiences with Viabahn stent graft","volume":"47","author":"Jebran","year":"2013","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.jvs.2014.12.062_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1583\/05-1799.1","article-title":"Value of the Hemobahn\/Viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience","volume":"13","author":"Fischer","year":"2006","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2014.12.062_bib16","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jvs.2012.03.010","article-title":"Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease","volume":"56","author":"Johnston","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2014.12.062_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jvir.2012.10.004","volume":"24","author":"Saxon","year":"2013","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2014.12.062_bib18","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.avsg.2013.01.019","article-title":"Comparison of graft patency, limb salvage, and antithrombotic therapy between prosthetic and autogenous below-knee bypass for critical limb ischemia","volume":"27","author":"Suckow","year":"2013","journal-title":"Ann Vasc Surg"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521415000646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521415000646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T21:50:03Z","timestamp":1537825803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521415000646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0741521415000646"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2014.12.062","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of antiplatelet\/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2014.12.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}